These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 15511475

  • 1. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
    Lin FC, Durkin AE, Ferguson MK.
    Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
    [Abstract] [Full Text] [Related]

  • 2. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
    Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Komaki R, Ajani JA, Roth JA.
    Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
    [Abstract] [Full Text] [Related]

  • 3. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
    Ruol A, Portale G, Castoro C, Merigliano S, Cagol M, Cavallin F, Chiarion Sileni V, Corti L, Rampado S, Costantini M, Ancona E.
    Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C, Taillier G, Van Seuningen I, Triboulet JP.
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [Abstract] [Full Text] [Related]

  • 5. Outcomes after trimodality therapy for esophageal cancer: the impact of histology on failure patterns.
    Koshy M, Greenwald BD, Hausner P, Krasna MJ, Horiba N, Battafarano RJ, Burrows W, Suntharalingam M.
    Am J Clin Oncol; 2011 Jun; 34(3):259-64. PubMed ID: 20686405
    [Abstract] [Full Text] [Related]

  • 6. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC, Untch B, Aranha GV, Mohideen N, Hantel A, Pickleman J.
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [Abstract] [Full Text] [Related]

  • 7. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH, Rong TH, Li XD, Hu Y, Ou W, Hu YH, Li Q.
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [Abstract] [Full Text] [Related]

  • 8. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
    Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA.
    Cancer; 2008 Sep 15; 113(6):1302-8. PubMed ID: 18623381
    [Abstract] [Full Text] [Related]

  • 9. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.
    Ann Surg; 2009 Mar 15; 249(3):392-6. PubMed ID: 19247024
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI, Miller DL.
    Ann Thorac Surg; 2008 Apr 15; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [Abstract] [Full Text] [Related]

  • 11. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
    Makary MA, Kiernan PD, Sheridan MJ, Tonnesen G, Hetrick V, Vaughan B, Graling P, Elster E.
    Am Surg; 2003 Aug 15; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
    [Abstract] [Full Text] [Related]

  • 12. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
    Internullo E, Moons J, Nafteux P, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Lerut T.
    Eur J Cardiothorac Surg; 2008 Jun 15; 33(6):1096-104. PubMed ID: 18407509
    [Abstract] [Full Text] [Related]

  • 13. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer.
    Berger AC, Scott WJ, Freedman G, Konski A, Weiner L, Cheng JD, Goldberg M.
    Semin Oncol; 2005 Dec 15; 32(6 Suppl 9):S16-20. PubMed ID: 16399424
    [Abstract] [Full Text] [Related]

  • 14. [How safe is high intrathoracic esophagogastrostomy?].
    Hölscher AH, Schröder W, Bollschweiler E, Beckurts KT, Schneider PM.
    Chirurg; 2003 Aug 15; 74(8):726-33. PubMed ID: 12928793
    [Abstract] [Full Text] [Related]

  • 15. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 16. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP.
    Br J Surg; 2006 Sep 01; 93(9):1077-83. PubMed ID: 16779882
    [Abstract] [Full Text] [Related]

  • 17. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
    Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H.
    J Thorac Cardiovasc Surg; 2009 Jan 01; 137(1):49-54. PubMed ID: 19154902
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 19. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma.
    Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL.
    Cancer; 2005 May 01; 103(9):1791-9. PubMed ID: 15779022
    [Abstract] [Full Text] [Related]

  • 20. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2894-902. PubMed ID: 18663531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.